Has Paul Lyons, MD received payments from drug or device companies?

Yes. Drug and device makers reported $705,295 in general payments to Paul Lyons, MD across 1,257 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Lyons, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Lyons, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Lyons, MD

Clinical Neurophysiology · Winchester, VANPI 1083656250

Payments from drug & device makers

$705,295in general payments, 2019–2025

Across 1,257 payments — averaging $561.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GW Research Limited$296K
Janssen Research & Development, LLC$89K
Livanova USA, Inc.$87K
UCB, Inc.$85K
SK Life Science, Inc.$57K
Jazz Pharmaceuticals Inc.$36K
plus $56K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GW Research Limited	13	$295,842
Janssen Research & Development, LLC	31	$88,556
Livanova USA, Inc.	63	$86,536
UCB, Inc.	231	$85,277
SK Life Science, Inc.	82	$57,197
Jazz Pharmaceuticals Inc.	77	$35,641
Greenwich Biosciences, Inc.	55	$19,000
UCB SA	4	$18,740
Neurelis, Inc.	26	$5,497
AbbVie(2 entities)	96	$1,303
Biogen	59	$953
Lilly USA, LLC	37	$724
Novartis	31	$634
AstraZeneca(2 entities)	29	$625
Eisai Inc.	31	$604
Pfizer	63	$578
Amgen(2 entities)	22	$499
Supernus Pharmaceuticals, Inc.	27	$455
Neuropace, Inc.	5	$447
Sanofi	22	$438
Lundbeck LLC	24	$422
Teva Pharmaceuticals USA, Inc.	22	$416
Medtronic	3	$269
Inspire Medical Systems, Inc.	7	$244
ANI Pharmaceuticals, Inc.	9	$240
Genentech USA, Inc.	22	$227
Sunovion Pharmaceuticals Inc.	13	$209
EMD Serono, Inc.	8	$182
MDD US Operations, LLC	3	$179
Tanabe Pharma America, Inc.	8	$170
Abbott	6	$149
Cadwell Industries, Inc	3	$143
Amneal Pharmaceuticals LLC	6	$141
Microtransponder, Inc.	1	$139
Bristol Myers Squibb	9	$133
Catalyst Pharmaceuticals, Inc.	6	$133
TG Therapeutics, Inc.	6	$132
Biocodex, Inc.	2	$132
Argenx US, Inc.	5	$127
Kyowa Kirin, Inc.	6	$120
Acorda Therapeutics, Inc	7	$119
CSL Behring	5	$116
Avanir Pharmaceuticals, Inc.	7	$112
Mallinckrodt Hospital Products Inc.	4	$107
ZOLL Respicardia, Inc.	1	$107
Merz Pharmaceuticals, LLC	4	$90
Harmony Biosciences LLC	4	$89
Monteris Medical Corporation	1	$88
Zogenix Inc.	2	$86
Grifols USA, LLC	5	$75
Sumitomo Pharma America, Inc.	4	$74
Biohaven Pharmaceutical Holding Company Ltd.	4	$74
GE HealthCare	3	$65
Axsome Therapeutics, Inc.	3	$65
Vanda Pharmaceuticals Inc.	2	$60
Otsuka America Pharmaceutical, Inc.	3	$55
Johnson & Johnson	3	$54
Aquestive Therapeutics, Inc.	2	$49
Neurocrine Biosciences, Inc.	3	$40
Immedica Pharma US, Inc.	2	$39

How this compares

Too few clinical neurophysiology providers in Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$228,275

Medicare patients

718

Services billed

3,104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical neurophysiology in Winchester

Sonia GillFairfax$8K
Henry Martin-YeboahAlexandria$3K
Eric GoldbergPortsmouth$2K
Divya ChauhanLeesburg$525
Noor MozahemRichmond$136
Saba NawazRichmond$136
Vivek SatyasiManassas$87

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →